Drugs / Prepopik
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PREPOPIK | — | 2012-07-16 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01928862 | Jun 2014 → Feb 2017 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01978509 Comparator | Sep 2013 → Mar 2019 | — | Mayo Clinic | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prepopik | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01978509 ↗ |